News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sarepta Therapeutics (SRPT) Announces Appointment Of John Hodgman As Interim Chairman


8/1/2014 9:10:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that John Hodgman, a member of Sarepta’s board of directors, has been named interim chairman, effective July 30, 2014. William Goolsbee, chairman of the company’s board of directors, has resigned as chairman and will continue to serve on the Sarepta board as an independent director.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES